We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Study: Teva's Copaxone the Better Treatment Option for MS
Study: Teva's Copaxone the Better Treatment Option for MS
April 13, 2007
Teva Pharmaceutical’s multiple sclerosis (MS) agent Copaxone is a better treatment for patients with relapsing-remitting MS compared with interferon beta drug products, a recent study found.